Edwards Lifesciences Corp
NYSE:EW
Edwards Lifesciences Corp
Cash from Investing Activities
Edwards Lifesciences Corp
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Edwards Lifesciences Corp
NYSE:EW
|
Cash from Investing Activities
$173.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cash from Investing Activities
-$658m
|
CAGR 3-Years
22%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
4%
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash from Investing Activities
-$2.6B
|
CAGR 3-Years
-84%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-18%
|
|
Stryker Corp
NYSE:SYK
|
Cash from Investing Activities
-$962m
|
CAGR 3-Years
41%
|
CAGR 5-Years
20%
|
CAGR 10-Years
8%
|
|
Abbott Laboratories
NYSE:ABT
|
Cash from Investing Activities
-$3.1B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-3%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash from Investing Activities
-$1.1B
|
CAGR 3-Years
9%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
See Also
What is Edwards Lifesciences Corp's Cash from Investing Activities?
Cash from Investing Activities
173.8m
USD
Based on the financial report for Dec 31, 2023, Edwards Lifesciences Corp's Cash from Investing Activities amounts to 173.8m USD.
What is Edwards Lifesciences Corp's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
18%
Over the last year, the Cash from Investing Activities growth was -31%.